NCT02951221View on ClinicalTrials.gov

New Formulation and Food Effect Study of BIIB074

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Trigeminal Neuralgia (TN)Other Neuropathic Pain
Interventions
DRUG

BIIB074 Treatment A

Lower dose RCF fasted

DRUG

BIIB074 Treatment B

Lower dose DCF fasted

DRUG

BIIB074 Treatment C

Higher dose DCF fasted

DRUG

BIIB074 Treatment D

Higher dose DCF fed

Trial Locations (1)

32117

Research Site, Daytona Beach

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY